Log In
Print
BCIQ
Print
Print this Print this
 

GSK3003891A

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionImmunostimulant vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent respiratory syncytial virus (RSV) infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today